We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DCI:NYSEDonaldson Company, Inc. Analysis

Data as of 2026-03-28 - not real-time

$83.87

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Donaldson’s share price is trading below its short‑term moving average while hovering just above its long‑term trend line, and the RSI is edging toward oversold territory, suggesting a potential technical rebound. The MACD histogram has turned positive, indicating early bullish momentum, and the stock is holding near a key support level in the low‑80s range. Recent earnings missed consensus expectations and operating margins contracted, reflecting pressure on profitability despite a modest revenue increase. The dividend remains modest with a payout ratio well within sustainable limits, providing a defensive cushion. Valuation metrics show a price‑to‑earnings ratio slightly under the industry average, yet a discounted cash‑flow model places intrinsic value far below the current market price, flagging a possible overvaluation. Analyst consensus leans toward a neutral stance with a target price that still offers upside from current levels. Overall, the blend of technical support, dividend safety, and a modest valuation discount creates a nuanced picture: short‑term price support is strong, medium‑term upside exists, but long‑term valuation concerns temper enthusiasm.
The industrial filtration sector remains cyclical and subject to environmental regulation, adding moderate sector and regulatory risk. Global exposure diversifies geographic risk, while the company’s USD‑centric cash flows keep currency risk low. Trading volume has been stable, indicating low liquidity risk. Investors should weigh the near‑term technical upside against the longer‑term valuation gap and margin pressures when forming a position.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Technical support near recent lows
  • RSI indicating oversold conditions
  • Recent earnings miss creating short‑term uncertainty

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Potential upside to analyst consensus target
  • Sustainable dividend with reasonable payout
  • Valuation spread relative to peers

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • DCF model suggests price may be stretched
  • Steady cash generation supporting dividend
  • Cyclical industry exposure and regulatory landscape

Key Metrics & Analysis

Financial Health

Revenue Growth3.00%
Profit Margin10.09%
P/E Ratio26.2
ROE24.27%
ROA11.80%
Debt/Equity43.22
P/B Ratio6.2
Op. Cash Flow$413.9M
Free Cash Flow$253.0M
Industry P/E28.1

Technical Analysis

TrendNeutral
RSI30.0
Support$82.01
Resistance$96.36
MA 20$87.58
MA 50$97.60
MA 200$85.03
MACDBullish
VolumeStable
Fear & Greed Index65.98

Valuation

Fair Value$28.85
Target Price$98.20
Upside/Downside17.09%
GradeOvervalued
TypeValue
Dividend Yield1.43%

Risk Assessment

Beta0.89
Volatility41.19%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.